Psoriasi (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Psoriasi" in Italian language version.

refsWebsite

Global rank Italian rank

141nih.gov

4^th place

9^th place

74doi.org

2^nd place

7^th place

56oadoi.org

799^th place

22^nd place

22archive.org

6^th place

8^th place

3web.archive.org

1^st place

1corriere.it

161^st place

3^rd place

1biochemia-medica.com

low place

1informahealthcare.com

low place

1pharmastar.it

low place

7,927^th place

1idsk.com

low place

1books.google.com

3^rd place

14^th place

1bbc.co.uk

8^th place

23^rd place

archive.org

AB. Kimball, A. Guerin; D. Latremouille-Viau; AP. Yu; S. Gupta; Y. Bao; P. Mulani, Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis., in Am J Med, vol. 123, n. 4, aprile 2010, pp. 350-7, DOI:10.1016/j.amjmed.2009.08.022, PMID 20362755.
R. Ghazizadeh, M. Tosa; M. Ghazizadeh, Clinical improvement in psoriasis with treatment of associated hyperlipidemia., in Am J Med Sci, vol. 341, n. 5, maggio 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.
Henry G. Piffard, "A Treatise On The Materia Medica And Therapeutics Of The Skin", Sampson Low, Marston, Searle & Rivington, 1881.
CM. Owen, RJ. Chalmers; T. O'Sullivan; CE. Griffiths, A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis., in Br J Dermatol, vol. 145, n. 6, dicembre 2001, pp. 886-90, PMID 11899140.
MA. Muñoz-Pérez, A. Rodriguez-Pichardo; F. Camacho; MA. Colmenero, Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse., in Br J Dermatol, vol. 139, n. 1, luglio 1998, pp. 33-9, PMID 9764146.
LM. Austin, M. Ozawa; T. Kikuchi; IB. Walters; JG. Krueger, The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients., in J Invest Dermatol, vol. 113, n. 5, novembre 1999, pp. 752-9, DOI:10.1046/j.1523-1747.1999.00749.x, PMID 10571730.
KH. Basavaraj, NM. Ashok; R. Rashmi; TK. Praveen, The role of drugs in the induction and/or exacerbation of psoriasis., in Int J Dermatol, vol. 49, n. 12, dicembre 2010, pp. 1351-61, DOI:10.1111/j.1365-4632.2010.04570.x, PMID 21091671.
L. Manolache, D. Petrescu-Seceleanu; V. Benea, Life events involvement in psoriasis onset/recurrence., in Int J Dermatol, vol. 49, n. 6, giugno 2010, pp. 636-41, DOI:10.1111/j.1365-4632.2009.04367.x, PMID 20618467.
Y. Lee, YH. Nam; JH. Lee; JK. Park; YJ. Seo, Hypocalcaemia-induced pustular psoriasis-like skin eruption., in Br J Dermatol, vol. 152, n. 3, marzo 2005, pp. 591-3, DOI:10.1111/j.1365-2133.2005.06460.x, PMID 15787848.
Gudjónsson JE, Kárason A, Antonsdóttir AA, Rúnarsdóttir EH, Gulcher JR, Stefánsson K, Valdimarsson H, HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features, in J. Invest. Dermatol., vol. 118, n. 2, 2002, pp. 362-5, DOI:10.1046/j.0022-202x.2001.01656.x, PMID 11841557.
M. Cargill, SJ. Schrodi; M. Chang; VE. Garcia; R. Brandon; KP. Callis; N. Matsunami; KG. Ardlie; D. Civello; JJ. Catanese; DU. Leong, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes., in Am J Hum Genet, vol. 80, n. 2, febbraio 2007, pp. 273-90, DOI:10.1086/511051, PMID 17236132.
DY. Leung, JB. Travers; R. Giorno; DA. Norris; R. Skinner; J. Aelion; LV. Kazemi; MH. Kim; AE. Trumble; M. Kotb, Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis., in J Clin Invest, vol. 96, n. 5, novembre 1995, pp. 2106-12, DOI:10.1172/JCI118263, PMID 7593594.
RJ. Chalmers, B. Kirby, Gluten and psoriasis., in Br J Dermatol, vol. 142, n. 1, gennaio 2000, pp. 5-7, PMID 10651687.
G. Michaëlsson, B. Gerdén; E. Hagforsen; B. Nilsson; I. Pihl-Lundin; W. Kraaz; G. Hjelmquist; L. Lööf, Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet., in Br J Dermatol, vol. 142, n. 1, gennaio 2000, pp. 44-51, PMID 10651693.
F. Sampogna, MM. Chren; CF. Melchi; P. Pasquini; S. Tabolli; D. Abeni, Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis., in Br J Dermatol, vol. 154, n. 2, febbraio 2006, pp. 325-31, DOI:10.1111/j.1365-2133.2005.06909.x, PMID 16433804.
L. Dubertret, U. Mrowietz; A. Ranki; PC. van de Kerkhof; S. Chimenti; T. Lotti; G. Schäfer, European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey., in Br J Dermatol, vol. 155, n. 4, ottobre 2006, pp. 729-36, DOI:10.1111/j.1365-2133.2006.07405.x, PMID 16965422.
SR. Feldman, AB. Fleischer; DM. Reboussin; SR. Rapp; ML. Exum; AR. Clark; L. Nurre, The self-administered psoriasis area and severity index is valid and reliable., in J Invest Dermatol, vol. 106, n. 1, gennaio 1996, pp. 183-6, PMID 8592072.
GD. Eslick, Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis., in Int J Dermatol, vol. 41, n. 11, novembre 2002, pp. 788-91, PMID 12453007.
AC. Miller, Anthralin cream as short contact therapy for psoriasis., in Cutis, vol. 35, n. 6, giugno 1985, pp. 578-82, PMID 4017653.
RK. Landow, New drugs for dermatologic diseases., in Dermatol Clin, vol. 6, n. 4, ottobre 1988, pp. 575-84, PMID 3067917.
PS. Yamauchi, D. Rizk; NJ. Lowe, Retinoid therapy for psoriasis., in Dermatol Clin, vol. 22, n. 4, ottobre 2004, pp. 467-76, x, DOI:10.1016/S0733-8635(03)00126-8, PMID 15450342.
Ghazizadeh R, Tosa M, Ghazizadeh M, Clinical Improvement in Psoriasis with Treatment of Associated Hyperlipidemia, in Am J Med Sci, vol. 341, n. 5, 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.

bbc.co.uk

Psoriasis Linked to Stroke Risk, BBC, agosto 2011.

biochemia-medica.com

Trifunović J, Miller L, Debeljak Ž, Horvat V, Pathologic patterns of interleukin 10 expression--a review, in Biochem Med (Zagreb), vol. 25, n. 1, 2015, pp. 36-48, DOI:10.11613/BM.2015.004, PMC 4401305, PMID 25672465.

books.google.com

Thomas P. Habif, 8, in Clinical dermatology a color guide to diagnosis and therapy, 5th, Edinburgh, Mosby Elsevier, 2010, ISBN 978-0-323-08037-8.

corriere.it

Le sigarette bruciano anche la pelle - Corriere.it

doi.org

dx.doi.org

WH. Boehncke, S. Boehncke, Research in practice: the systemic aspects of psoriasis., in J Dtsch Dermatol Ges, vol. 6, n. 8, agosto 2008, pp. 622-5, DOI:10.1111/j.1610-0387.2008.06785.x, PMID 18564207.
WH. Boehncke, S. Boehncke, Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives., in Curr Rheumatol Rep, vol. 14, n. 4, agosto 2012, pp. 343-8, DOI:10.1007/s11926-012-0260-8, PMID 22562431.
T. Xu, Y. Zhang, Association Of Psoriasis With Stroke And Myocardial Infarction: Meta Analysis Of Cohort Studies., in Br J Dermatol, agosto 2012, DOI:10.1111/bjd.12002, PMID 22897416.
AB. Kimball, A. Guerin; D. Latremouille-Viau; AP. Yu; S. Gupta; Y. Bao; P. Mulani, Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis., in Am J Med, vol. 123, n. 4, aprile 2010, pp. 350-7, DOI:10.1016/j.amjmed.2009.08.022, PMID 20362755.
R. Ghazizadeh, M. Tosa; M. Ghazizadeh, Clinical improvement in psoriasis with treatment of associated hyperlipidemia., in Am J Med Sci, vol. 341, n. 5, maggio 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.
C. Kahl, B. Hansen; K. Reich, [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy]., in Hautarzt, vol. 63, n. 3, marzo 2012, pp. 184-91, DOI:10.1007/s00105-011-2228-4, PMID 22382303.
MS. Day, D. Nam; S. Goodman; EP. Su; M. Figgie, Psoriatic arthritis., in J Am Acad Orthop Surg, vol. 20, n. 1, gennaio 2012, pp. 28-37, DOI:10.5435/JAAOS-20-01-028, PMID 22207516.
H. Takahashi, K. Nakamura; F. Kaneko; H. Nakagawa; H. Iizuka, Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008., in J Dermatol, vol. 38, n. 12, dicembre 2011, pp. 1125-9, DOI:10.1111/j.1346-8138.2010.01145.x, PMID 21951304.
MA. de Rie, AY. Goedkoop; JD. Bos, Overview of psoriasis., in Dermatol Ther, vol. 17, n. 5, 2004, pp. 341-9, DOI:10.1111/j.1396-0296.2004.04037.x, PMID 15379769.
JM. Gelfand, R. Weinstein; SB. Porter; AL. Neimann; JA. Berlin; DJ. Margolis, Prevalence and treatment of psoriasis in the United Kingdom: a population-based study., in Arch Dermatol, vol. 141, n. 12, dicembre 2005, pp. 1537-41, DOI:10.1001/archderm.141.12.1537, PMID 16365254.
L. Naldi, P. Colombo; EB. Placchesi; R. Piccitto; L. Chatenoud; C. La Vecchia, Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population., in Dermatology, vol. 208, n. 1, 2004, pp. 38-42, DOI:10.1159/000075044, PMID 14730235.
R. Parisi, DP. Symmons; CE. Griffiths; DM. Ashcroft, Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence., in J Invest Dermatol, settembre 2012, DOI:10.1038/jid.2012.339, PMID 23014338.
V. Chandran, SP. Raychaudhuri, Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis., in J Autoimmun, vol. 34, n. 3, maggio 2010, pp. J314-21, DOI:10.1016/j.jaut.2009.12.001, PMID 20034760.
R. Zenz, R. Eferl; L. Kenner; L. Florin; L. Hummerich; D. Mehic; H. Scheuch; P. Angel; E. Tschachler; EF. Wagner, Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins., in Nature, vol. 437, n. 7057, settembre 2005, pp. 369-75, DOI:10.1038/nature03963, PMID 16163348.
R. de Cid, E. Riveira-Munoz; PL. Zeeuwen; J. Robarge; W. Liao; EN. Dannhauser; E. Giardina; PE. Stuart; R. Nair; C. Helms; G. Escaramís, Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis., in Nat Genet, vol. 41, n. 2, febbraio 2009, pp. 211-5, DOI:10.1038/ng.313, PMID 19169253.
L. Naldi, L. Peli; F. Parazzini; CF. Carrel, Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study., in J Am Acad Dermatol, vol. 44, n. 3, marzo 2001, pp. 433-8, DOI:10.1067/mjd.2001.110876, PMID 11209111.
CM. Owen, RJ. Chalmers; T. O'Sullivan; CE. Griffiths, Antistreptococcal interventions for guttate and chronic plaque psoriasis., in Cochrane Database Syst Rev, n. 2, 2000, pp. CD001976, DOI:10.1002/14651858.CD001976, PMID 10796842.
J. Badger, TG. Berger; C. Gambla; JY. Koo, HIV and psoriasis., in Clin Rev Allergy Immunol, vol. 14, n. 4, pp. 417-31, DOI:10.1007/BF02771755, PMID 9040969.
E. Mallon, CB. Bunker, HIV-associated psoriasis., in AIDS Patient Care STDS, vol. 14, n. 5, maggio 2000, pp. 239-46, DOI:10.1089/108729100317696, PMID 10833810.
LM. Austin, M. Ozawa; T. Kikuchi; IB. Walters; JG. Krueger, The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients., in J Invest Dermatol, vol. 113, n. 5, novembre 1999, pp. 752-9, DOI:10.1046/j.1523-1747.1999.00749.x, PMID 10571730.
E. Dika, F. Bardazzi; R. Balestri; HI. Maibach, Environmental factors and psoriasis., in Curr Probl Dermatol, vol. 35, 2007, pp. 118-35, DOI:10.1159/0000106419, PMID 17641494.
M. Afshar, AD. Martinez; RL. Gallo; TR. Hata, Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases., in J Eur Acad Dermatol Venereol, giugno 2012, DOI:10.1111/j.1468-3083.2012.04582.x, PMID 22671985.
L. Fry, BS. Baker, Triggering psoriasis: the role of infections and medications., in Clin Dermatol, vol. 25, n. 6, pp. 606-15, DOI:10.1016/j.clindermatol.2007.08.015, PMID 18021899.
KH. Basavaraj, NM. Ashok; R. Rashmi; TK. Praveen, The role of drugs in the induction and/or exacerbation of psoriasis., in Int J Dermatol, vol. 49, n. 12, dicembre 2010, pp. 1351-61, DOI:10.1111/j.1365-4632.2010.04570.x, PMID 21091671.
S. Jankovic, M. Raznatovic; J. Marinkovic; J. Jankovic; N. Maksimovic, Risk factors for psoriasis: A case-control study., in J Dermatol, vol. 36, n. 6, giugno 2009, pp. 328-34, DOI:10.1111/j.1346-8138.2009.00648.x, PMID 19500181.
L. Manolache, D. Petrescu-Seceleanu; V. Benea, Life events involvement in psoriasis onset/recurrence., in Int J Dermatol, vol. 49, n. 6, giugno 2010, pp. 636-41, DOI:10.1111/j.1365-4632.2009.04367.x, PMID 20618467.
RP. Dellavalle, KR. Johnson, Do smoking, obesity, and stress cause psoriasis?, in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. vi-vii, DOI:10.1111/j.0022-202X.2005.23792.x, PMID 15982291.
L. Naldi, L. Chatenoud; D. Linder; A. Belloni Fortina; A. Peserico; AR. Virgili; PL. Bruni; V. Ingordo; G. Lo Scocco; C. Solaroli; D. Schena, Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study., in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. 61-7, DOI:10.1111/j.0022-202X.2005.23681.x, PMID 15982303.
Y. Lee, YH. Nam; JH. Lee; JK. Park; YJ. Seo, Hypocalcaemia-induced pustular psoriasis-like skin eruption., in Br J Dermatol, vol. 152, n. 3, marzo 2005, pp. 591-3, DOI:10.1111/j.1365-2133.2005.06460.x, PMID 15787848.
Diani M, Altomare G, Reali E, T cell responses in psoriasis and psoriatic arthritis, in Autoimmun Rev, vol. 14, n. 4, 2015, pp. 286-92, DOI:10.1016/j.autrev.2014.11.012, PMID 25445403.
V. Chandran, CT. Schentag; JE. Brockbank; FJ. Pellett; S. Shanmugarajah; SM. Toloza; P. Rahman; DD. Gladman, Familial aggregation of psoriatic arthritis., in Ann Rheum Dis, vol. 68, n. 5, maggio 2009, pp. 664-7, DOI:10.1136/ard.2008.089367, PMID 18524791.
FO. Nestle, DH. Kaplan; J. Barker, Psoriasis., in N Engl J Med, vol. 361, n. 5, luglio 2009, pp. 496-509, DOI:10.1056/NEJMra0804595, PMID 19641206.
LD. Sun, W. Li; S. Yang; X. Fan; KL. Yan; YH. Liang; M. Gao; Y. Cui; FL. Xiao; WH. Du; KY. Zhang, Evidence for a novel psoriasis susceptibility locus at 9q33-9q34 in Chinese Hans., in J Invest Dermatol, vol. 127, n. 5, maggio 2007, pp. 1140-4, DOI:10.1038/sj.jid.5700671, PMID 17205061.
Gudjónsson JE, Kárason A, Antonsdóttir AA, Rúnarsdóttir EH, Gulcher JR, Stefánsson K, Valdimarsson H, HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features, in J. Invest. Dermatol., vol. 118, n. 2, 2002, pp. 362-5, DOI:10.1046/j.0022-202x.2001.01656.x, PMID 11841557.
Yim SH, Jung SH, Chung B, Chung YJ, Clinical implications of copy number variations in autoimmune disorders, in Korean J. Intern. Med., vol. 30, n. 3, 2015, pp. 294-304, DOI:10.3904/kjim.2015.30.3.294, PMC 4438283, PMID 25995659.
M. Cargill, SJ. Schrodi; M. Chang; VE. Garcia; R. Brandon; KP. Callis; N. Matsunami; KG. Ardlie; D. Civello; JJ. Catanese; DU. Leong, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes., in Am J Hum Genet, vol. 80, n. 2, febbraio 2007, pp. 273-90, DOI:10.1086/511051, PMID 17236132.
RP. Nair, A. Ruether; PE. Stuart; S. Jenisch; T. Tejasvi; R. Hiremagalore; S. Schreiber; D. Kabelitz; HW. Lim; JJ. Voorhees; E. Christophers, Polymorphisms of the IL12B and IL23R genes are associated with psoriasis., in J Invest Dermatol, vol. 128, n. 7, luglio 2008, pp. 1653-61, DOI:10.1038/sj.jid.5701255, PMID 18219280.
CT. Jordan, L. Cao; ED. Roberson; S. Duan; CA. Helms; RP. Nair; KC. Duffin; PE. Stuart; D. Goldgar; G. Hayashi; EH. Olfson, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 796-808, DOI:10.1016/j.ajhg.2012.03.013, PMID 22521419.
CT. Jordan, L. Cao; ED. Roberson; KC. Pierson; CF. Yang; CE. Joyce; C. Ryan; S. Duan; CA. Helms; Y. Liu; Y. Chen, PSORS2 is due to mutations in CARD14., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 784-95, DOI:10.1016/j.ajhg.2012.03.012, PMID 22521418.
DY. Leung, JB. Travers; R. Giorno; DA. Norris; R. Skinner; J. Aelion; LV. Kazemi; MH. Kim; AE. Trumble; M. Kotb, Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis., in J Clin Invest, vol. 96, n. 5, novembre 1995, pp. 2106-12, DOI:10.1172/JCI118263, PMID 7593594.
Boehncke WH, Schön MP, Psoriasis, in Lancet, 2015, DOI:10.1016/S0140-6736(14)61909-7, PMID 26025581.
Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C, Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety, in J Psychosom Res, 2015, DOI:10.1016/j.jpsychores.2015.04.008, PMID 25935351.
Trifunović J, Miller L, Debeljak Ž, Horvat V, Pathologic patterns of interleukin 10 expression--a review, in Biochem Med (Zagreb), vol. 25, n. 1, 2015, pp. 36-48, DOI:10.11613/BM.2015.004, PMC 4401305, PMID 25672465.
G. Michaëlsson, S. Ahs; I. Hammarström; IP. Lundin; E. Hagforsen, Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis., in Acta Derm Venereol, vol. 83, n. 6, 2003, pp. 425-9, DOI:10.1080/00015550310015022, PMID 14690336.
F. Sampogna, MM. Chren; CF. Melchi; P. Pasquini; S. Tabolli; D. Abeni, Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis., in Br J Dermatol, vol. 154, n. 2, febbraio 2006, pp. 325-31, DOI:10.1111/j.1365-2133.2005.06909.x, PMID 16433804.
L. Dubertret, U. Mrowietz; A. Ranki; PC. van de Kerkhof; S. Chimenti; T. Lotti; G. Schäfer, European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey., in Br J Dermatol, vol. 155, n. 4, ottobre 2006, pp. 729-36, DOI:10.1111/j.1365-2133.2006.07405.x, PMID 16965422.
MJ. Bhosle, A. Kulkarni; SR. Feldman; R. Balkrishnan, Quality of life in patients with psoriasis., in Health Qual Life Outcomes, vol. 4, 2006, p. 35, DOI:10.1186/1477-7525-4-35, PMID 16756666.
D. Globe, MS. Bayliss; DJ. Harrison, The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups., in Health Qual Life Outcomes, vol. 7, 2009, p. 62, DOI:10.1186/1477-7525-7-62, PMID 19580674.
A. Gottlieb, J. Feng; DJ. Harrison; D. Globe, Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis., in J Am Acad Dermatol, vol. 63, n. 4, ottobre 2010, pp. 580-6, DOI:10.1016/j.jaad.2009.09.049, PMID 20599294.
A. Krol, B. Krafchik, The differential diagnosis of atopic dermatitis in childhood., in Dermatol Ther, vol. 19, n. 2, Ago 2009, pp. 73-82, DOI:10.1111/j.1529-8019.2006.00058.x, PMID 16669989.
N. Balato, L. Di Costanzo; A. Balato, Differential diagnosis of psoriasis., in J Rheumatol Suppl, vol. 83, agosto 2009, pp. 24-5, DOI:10.3899/jrheum.090216, PMID 19661533.
A. Menter, CE. Griffiths, Current and future management of psoriasis., in Lancet, vol. 370, n. 9583, luglio 2007, pp. 272-84, DOI:10.1016/S0140-6736(07)61129-5, PMID 17658398.
JC. Beani, M. Jeanmougin, [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]., in Ann Dermatol Venereol, vol. 137, n. 1, gennaio 2010, pp. 21-31, DOI:10.1016/j.annder.2009.12.004, PMID 20110064.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 11-21, DOI:10.1111/j.1468-3083.2012.04519.x, PMID 22512676.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 22-31, DOI:10.1111/j.1468-3083.2012.04520.x, PMID 22512677.
RV. Patel, LN. Clark; M. Lebwohl; JM. Weinberg, Treatments for psoriasis and the risk of malignancy., in J Am Acad Dermatol, vol. 60, n. 6, giugno 2009, pp. 1001-17, DOI:10.1016/j.jaad.2008.12.031, PMID 19344980.
PS. Yamauchi, D. Rizk; NJ. Lowe, Retinoid therapy for psoriasis., in Dermatol Clin, vol. 22, n. 4, ottobre 2004, pp. 467-76, x, DOI:10.1016/S0733-8635(03)00126-8, PMID 15450342.
Lernia V, Tasin L, Pellicano R, Zumiani G, Albertini G, Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis ^{[collegamento interrotto]}, in J Dermatolog Treat, vol. 23, n. 6, 2012, pp. 404-9, DOI:10.3109/09546634.2011.593489, PMID 21781016.
Benson JM, Peritt D, Scallon BJ, et al., Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders, in MAbs, vol. 3, n. 6, 2011, pp. 535-45, DOI:10.4161/mabs.3.6.17815, PMID 22123062.
Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH, Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses, in Br J Dermatol, vol. 168, n. 5, 2013, pp. 954-67, DOI:10.1111/bjd.12276/full, PMID 23413913.
Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F., Genetics of Psoriasis and Pharmacogenetics of Biological Drugs, in Autoimmune Dis., vol. 2013, n. 613086, agosto 2013, p. 613086, DOI:10.1155/2013/613086, PMC 3771250, PMID 24069534.
Parrish L., Psoriasis: symptoms, treatments and its impact on quality of life, in Br J Community Nurs, vol. 17, n. 11, 2012, pp. 524, 526, 528, DOI:10.12968/bjcn.2012.17.11.524, PMID 23124421.
Dessinioti C, Katsambas A, Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies, in Clin Dermatol, vol. 31, n. 4, 2013, pp. 343-51, DOI:10.1016/j.clindermatol.2013.01.001, PMID 23806151.
Menter, A.,Gottlieb, A., Feldman, S.R., Van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., Lebwohl, M., Koo, JY., Elmets, C.A., Korman, N.J., Beutner, K.R., Bhushan, R., Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics, in J Am Acad Dermatol, vol. 58, n. 5, maggio 2008, pp. 826-50, DOI:10.1016/j.jaad.2008.02.039, PMID 18423260.
Gelmetti C, Therapeutic moisturizers as adjuvant therapy for psoriasis patients, in Am J Clin Dermatol, vol. 10, Suppl 1, gennaio 2009, pp. 7-12, DOI:10.2165/0128071-200910001-00002, PMID 19209948.
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R, Quality of life in patients with psoriasis, in Health Qual Life Outcomes, vol. 4, 2006, p. 35, DOI:10.1186/1477-7525-4-35, PMC 1501000, PMID 16756666.
P Magin, Appearance-related bullying and skin disorders., in Clinics in dermatology, vol. 31, n. 1, Jan–Feb 2013, pp. 66-71, DOI:10.1016/j.clindermatol.2011.11.009, PMID 23245976.
Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Kimball AB, Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-related Comorbidities, in Am J Med, vol. 127, n. 12, dicembre 2014, pp. 1148-53, DOI:10.1016/j.amjmed.2014.08.008, PMID 25149424.
Armstrong AW, Harskamp CT, Armstrong EJ, Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis, in JAMA Dermatol, vol. 149, n. 1, gennaio 2013, pp. 84-91, DOI:10.1001/2013.jamadermatol.406, PMID 23407990.
Richard MA, Barnetche T, Horreau C, Brenaut E, Pouplard C, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Ortonne JP, Paul C., Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion, in J Eur Acad Dermatol Venereol, vol. 27, Supplement 3, agosto 2013, pp. 2-11, DOI:10.1111/jdv.12162, PMID 23845148.
Armstrong AW, Harskamp CT, Armstrong EJ, The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies, in J Hypertens, vol. 31, n. 3, 2013, pp. 433-42, DOI:10.1097/HJH.0b013e32835bcce1, PMID 23249828.
Ghazizadeh R, Tosa M, Ghazizadeh M, Clinical Improvement in Psoriasis with Treatment of Associated Hyperlipidemia, in Am J Med Sci, vol. 341, n. 5, 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP, Diagnosis and classification of psoriasis, in Autoimmun Rev, S1568-9972, n. 14, gennaio 2014, pp. 00020-2, DOI:10.1016/j.autrev.2014.01.008, PMID 24434359.
Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR, Risk of cardiovascular disorders in psoriasis patients: current and future, in Am J Clin Dermatol, vol. 14, n. 1, febbraio 2013, pp. 1-7, DOI:10.1007/s40257-012-0005-5, PMID 23329076.

idsk.com

news.idsk.com

Approvazione di Ustekinumab nel trattamento della psoriasi a placche da moderata a grave, su news.idsk.com.

informahealthcare.com

Lernia V, Tasin L, Pellicano R, Zumiani G, Albertini G, Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis ^{[collegamento interrotto]}, in J Dermatolog Treat, vol. 23, n. 6, 2012, pp. 404-9, DOI:10.3109/09546634.2011.593489, PMID 21781016.

nih.gov

ncbi.nlm.nih.gov

WH. Boehncke, S. Boehncke, Research in practice: the systemic aspects of psoriasis., in J Dtsch Dermatol Ges, vol. 6, n. 8, agosto 2008, pp. 622-5, DOI:10.1111/j.1610-0387.2008.06785.x, PMID 18564207.
WH. Boehncke, S. Boehncke, Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives., in Curr Rheumatol Rep, vol. 14, n. 4, agosto 2012, pp. 343-8, DOI:10.1007/s11926-012-0260-8, PMID 22562431.
T. Xu, Y. Zhang, Association Of Psoriasis With Stroke And Myocardial Infarction: Meta Analysis Of Cohort Studies., in Br J Dermatol, agosto 2012, DOI:10.1111/bjd.12002, PMID 22897416.
AB. Kimball, A. Guerin; D. Latremouille-Viau; AP. Yu; S. Gupta; Y. Bao; P. Mulani, Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis., in Am J Med, vol. 123, n. 4, aprile 2010, pp. 350-7, DOI:10.1016/j.amjmed.2009.08.022, PMID 20362755.
R. Ghazizadeh, M. Tosa; M. Ghazizadeh, Clinical improvement in psoriasis with treatment of associated hyperlipidemia., in Am J Med Sci, vol. 341, n. 5, maggio 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.
C. Kahl, B. Hansen; K. Reich, [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy]., in Hautarzt, vol. 63, n. 3, marzo 2012, pp. 184-91, DOI:10.1007/s00105-011-2228-4, PMID 22382303.
MS. Day, D. Nam; S. Goodman; EP. Su; M. Figgie, Psoriatic arthritis., in J Am Acad Orthop Surg, vol. 20, n. 1, gennaio 2012, pp. 28-37, DOI:10.5435/JAAOS-20-01-028, PMID 22207516.
A. Shai, D. Vardy; A. Zvulunov, [Psoriasis, biblical afflictions and patients' dignity]., in Harefuah, vol. 141, n. 5, maggio 2002, pp. 479-82, 496, PMID 12073533.
L. Nardelli, [Psoriasis in the history of medicine]., in G Ital Dermatol, vol. 100, Lug-Ago 1959, pp. 363-88, PMID 14426024.
LK. Eckes, [Psoriasis and leprosy in the light of common history. A contribution on epidemiology and differential diagnosis]., in Hautarzt, vol. 29, n. 6, giugno 1978, pp. 331-6, PMID 350808.
A. Lyell, Leprosy and psoriasis., in J Am Acad Dermatol, vol. 16, 3 Pt 1, marzo 1987, pp. 620-2, PMID 3546422.
FO. Meenan, A note on the history of psoriasis., in Ir J Med Sci, n. 351, marzo 1955, pp. 141-2, PMID 14353580.
FS. Glickman, Lepra, psora, psoriasis., in J Am Acad Dermatol, vol. 14, 5 Pt 1, maggio 1986, pp. 863-6, PMID 3519699.
K. Holubar, Psoriasis--100 years ago., in Dermatologica, vol. 180, n. 1, 1990, pp. 1-4, PMID 1968402.
B. Gordon, PM. Inman; P. Trinder, Mercury absorption and psoriasis., in Br Med J, vol. 2, n. 5003, novembre 1956, pp. 1202-6, PMID 13364416.
F. Kern, N. Roberts; L. Ostlere; J. Langtry; RC. Staughton, Ammoniated mercury ointment as a cause of peripheral neuropathy., in Dermatologica, vol. 183, n. 4, 1991, pp. 280-2, PMID 1667099.
EM. Farber, History of the treatment of psoriasis., in J Am Acad Dermatol, vol. 27, n. 4, ottobre 1992, pp. 640-5, PMID 1401327.
JR. Sorenson, W. Hangarter, Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate., in Inflammation, vol. 2, n. 3, settembre 1977, pp. 217-38, PMID 367963.
RA. Schwartz, Arsenic and the skin., in Int J Dermatol, vol. 36, n. 4, aprile 1997, pp. 241-50, PMID 9169318.
B. Lindelöf, Grenz ray therapy in dermatology. An experimental, clinical and epidemiological study., in Acta Derm Venereol Suppl (Stockh), vol. 132, 1987, pp. 1-67, PMID 3481149.
B. Lindelöf, [Grenz ray therapy]., in Hautarzt, vol. 40, n. 1, gennaio 1989, pp. 4-7, PMID 2646248.
H. Takahashi, K. Nakamura; F. Kaneko; H. Nakagawa; H. Iizuka, Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008., in J Dermatol, vol. 38, n. 12, dicembre 2011, pp. 1125-9, DOI:10.1111/j.1346-8138.2010.01145.x, PMID 21951304.
C. Bonifati, M. Carducci; A. Mussi; L. D'Auria; F. Ameglio, Recognition and treatment of psoriasis. Special considerations in elderly patients., in Drugs Aging, vol. 12, n. 3, marzo 1998, pp. 177-90, PMID 9534019.
MA. de Rie, AY. Goedkoop; JD. Bos, Overview of psoriasis., in Dermatol Ther, vol. 17, n. 5, 2004, pp. 341-9, DOI:10.1111/j.1396-0296.2004.04037.x, PMID 15379769.
A. Kawada, T. Tezuka; Y. Nakamizo; H. Kimura; H. Nakagawa; M. Ohkido; A. Ozawa; A. Ohkawara; H. Kobayashi; S. Harada; A. Igarashi, A survey of psoriasis patients in Japan from 1982 to 2001., in J Dermatol Sci, vol. 31, n. 1, febbraio 2003, pp. 59-64, PMID 12615365.
JM. Gelfand, R. Weinstein; SB. Porter; AL. Neimann; JA. Berlin; DJ. Margolis, Prevalence and treatment of psoriasis in the United Kingdom: a population-based study., in Arch Dermatol, vol. 141, n. 12, dicembre 2005, pp. 1537-41, DOI:10.1001/archderm.141.12.1537, PMID 16365254.
L. Naldi, P. Colombo; EB. Placchesi; R. Piccitto; L. Chatenoud; C. La Vecchia, Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population., in Dermatology, vol. 208, n. 1, 2004, pp. 38-42, DOI:10.1159/000075044, PMID 14730235.
R. Parisi, DP. Symmons; CE. Griffiths; DM. Ashcroft, Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence., in J Invest Dermatol, settembre 2012, DOI:10.1038/jid.2012.339, PMID 23014338.
V. Chandran, SP. Raychaudhuri, Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis., in J Autoimmun, vol. 34, n. 3, maggio 2010, pp. J314-21, DOI:10.1016/j.jaut.2009.12.001, PMID 20034760.
R. Zenz, R. Eferl; L. Kenner; L. Florin; L. Hummerich; D. Mehic; H. Scheuch; P. Angel; E. Tschachler; EF. Wagner, Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins., in Nature, vol. 437, n. 7057, settembre 2005, pp. 369-75, DOI:10.1038/nature03963, PMID 16163348.
R. de Cid, E. Riveira-Munoz; PL. Zeeuwen; J. Robarge; W. Liao; EN. Dannhauser; E. Giardina; PE. Stuart; R. Nair; C. Helms; G. Escaramís, Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis., in Nat Genet, vol. 41, n. 2, febbraio 2009, pp. 211-5, DOI:10.1038/ng.313, PMID 19169253.
NJ. Fiumara, Psoriasis of the penis: Koebner reaction. Following oral genital exposure., in J Am Vener Dis Assoc, vol. 3, 2 Pt 1, dicembre 1976, pp. 59-60, PMID 1010767.
EW. Rosenberg, PW. Noah, The Koebner phenomenon and the microbial basis of psoriasis., in J Am Acad Dermatol, vol. 18, 1 Pt 1, gennaio 1988, pp. 151-8, PMID 3279081.
RM. Rosen, Annular pustular psoriasis induced by UV radiation from tanning salon use., in J Am Acad Dermatol, vol. 25, 2 Pt 1, agosto 1991, pp. 336-7, PMID 1918477.
A. Rebora, Candida and psoriasis., in Acta Derm Venereol, vol. 84, n. 2, 2004, pp. 175; author reply 175, PMID 15206710.
A. Waldman, A. Gilhar; L. Duek; I. Berdicevsky, Incidence of Candida in psoriasis--a study on the fungal flora of psoriatic patients., in Mycoses, vol. 44, n. 3-4, maggio 2001, pp. 77-81, PMID 11413927.
L. Naldi, L. Peli; F. Parazzini; CF. Carrel, Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study., in J Am Acad Dermatol, vol. 44, n. 3, marzo 2001, pp. 433-8, DOI:10.1067/mjd.2001.110876, PMID 11209111.
CM. Owen, RJ. Chalmers; T. O'Sullivan; CE. Griffiths, A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis., in Br J Dermatol, vol. 145, n. 6, dicembre 2001, pp. 886-90, PMID 11899140.
CM. Owen, RJ. Chalmers; T. O'Sullivan; CE. Griffiths, Antistreptococcal interventions for guttate and chronic plaque psoriasis., in Cochrane Database Syst Rev, n. 2, 2000, pp. CD001976, DOI:10.1002/14651858.CD001976, PMID 10796842.
BS. Baker, AV. Owles; L. Fry, A possible role for vaccination in the treatment of psoriasis?, in G Ital Dermatol Venereol, vol. 143, n. 2, aprile 2008, pp. 105-17, PMID 18833037.
EW. Rosenberg, PW. Noah; RB. Skinner, Microorganisms and psoriasis., in J Natl Med Assoc, vol. 86, n. 4, aprile 1994, pp. 305-10, PMID 8040907.
EW. Rosenberg, PW. Noah; RB. Skinner; R. Vander Zwaag; SK. West; JF. Browder, Microbial associations of 167 patients with psoriasis., in Acta Derm Venereol Suppl (Stockh), vol. 146, 1989, pp. 72-4; discussion 75, PMID 2609890.
FC. Arnett, JD. Reveille; M. Duvic, Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection., in Rheum Dis Clin North Am, vol. 17, n. 1, febbraio 1991, pp. 59-78, PMID 2041889.
MA. Muñoz-Pérez, A. Rodriguez-Pichardo; F. Camacho; MA. Colmenero, Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse., in Br J Dermatol, vol. 139, n. 1, luglio 1998, pp. 33-9, PMID 9764146.
J. Badger, TG. Berger; C. Gambla; JY. Koo, HIV and psoriasis., in Clin Rev Allergy Immunol, vol. 14, n. 4, pp. 417-31, DOI:10.1007/BF02771755, PMID 9040969.
TA. Maurer, Dermatologic manifestations of HIV infection., in Top HIV Med, vol. 13, n. 5, pp. 149-54, PMID 16377853.
DJ. Fife, JM. Waller; EW. Jeffes; JY. Koo, Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles., in Dermatol Online J, vol. 13, n. 2, 2007, p. 4, PMID 17498423.
E. Mallon, CB. Bunker, HIV-associated psoriasis., in AIDS Patient Care STDS, vol. 14, n. 5, maggio 2000, pp. 239-46, DOI:10.1089/108729100317696, PMID 10833810.
LM. Austin, M. Ozawa; T. Kikuchi; IB. Walters; JG. Krueger, The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients., in J Invest Dermatol, vol. 113, n. 5, novembre 1999, pp. 752-9, DOI:10.1046/j.1523-1747.1999.00749.x, PMID 10571730.
R. Wolf, V. Ruocco, Triggered psoriasis., in Adv Exp Med Biol, vol. 455, 1999, pp. 221-5, PMID 10599347.
E. Dika, F. Bardazzi; R. Balestri; HI. Maibach, Environmental factors and psoriasis., in Curr Probl Dermatol, vol. 35, 2007, pp. 118-35, DOI:10.1159/0000106419, PMID 17641494.
M. O'Brien, J. Koo, The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis., in J Drugs Dermatol, vol. 5, n. 5, maggio 2006, pp. 426-32, PMID 16703778.
M. Afshar, AD. Martinez; RL. Gallo; TR. Hata, Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases., in J Eur Acad Dermatol Venereol, giugno 2012, DOI:10.1111/j.1468-3083.2012.04582.x, PMID 22671985.
V. Milavec-Puretić, M. Mance; R. Ceović; J. Lipozenčić, Drug induced psoriasis., in Acta Dermatovenerol Croat, vol. 19, n. 1, 2011, pp. 39-42, PMID 21489366.
L. Fry, BS. Baker, Triggering psoriasis: the role of infections and medications., in Clin Dermatol, vol. 25, n. 6, pp. 606-15, DOI:10.1016/j.clindermatol.2007.08.015, PMID 18021899.
EA. Abel, LM. DiCicco; EK. Orenberg; JE. Fraki; EM. Farber, Drugs in exacerbation of psoriasis., in J Am Acad Dermatol, vol. 15, 5 Pt 1, novembre 1986, pp. 1007-22, PMID 2878015.
KH. Basavaraj, NM. Ashok; R. Rashmi; TK. Praveen, The role of drugs in the induction and/or exacerbation of psoriasis., in Int J Dermatol, vol. 49, n. 12, dicembre 2010, pp. 1351-61, DOI:10.1111/j.1365-4632.2010.04570.x, PMID 21091671.
SP. Raychaudhuri, J. Gross, Psoriasis risk factors: role of lifestyle practices., in Cutis, vol. 66, n. 5, novembre 2000, pp. 348-52, PMID 11107520.
S. Jankovic, M. Raznatovic; J. Marinkovic; J. Jankovic; N. Maksimovic, Risk factors for psoriasis: A case-control study., in J Dermatol, vol. 36, n. 6, giugno 2009, pp. 328-34, DOI:10.1111/j.1346-8138.2009.00648.x, PMID 19500181.
L. Manolache, D. Petrescu-Seceleanu; V. Benea, Life events involvement in psoriasis onset/recurrence., in Int J Dermatol, vol. 49, n. 6, giugno 2010, pp. 636-41, DOI:10.1111/j.1365-4632.2009.04367.x, PMID 20618467.
SM. Behnam, SE. Behnam; JY. Koo, Alcohol as a risk factor for plaque-type psoriasis., in Cutis, vol. 76, n. 3, settembre 2005, pp. 181-5, PMID 16268261.
RP. Dellavalle, KR. Johnson, Do smoking, obesity, and stress cause psoriasis?, in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. vi-vii, DOI:10.1111/j.0022-202X.2005.23792.x, PMID 15982291.
L. Naldi, L. Chatenoud; D. Linder; A. Belloni Fortina; A. Peserico; AR. Virgili; PL. Bruni; V. Ingordo; G. Lo Scocco; C. Solaroli; D. Schena, Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study., in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. 61-7, DOI:10.1111/j.0022-202X.2005.23681.x, PMID 15982303.
MA. Gupta, AK. Gupta; CN. Ellis; JJ. Voorhees, Some psychosomatic aspects of psoriasis., in Adv Dermatol, vol. 5, 1990, pp. 21-30; discussion 31, PMID 2204373.
Y. Lee, YH. Nam; JH. Lee; JK. Park; YJ. Seo, Hypocalcaemia-induced pustular psoriasis-like skin eruption., in Br J Dermatol, vol. 152, n. 3, marzo 2005, pp. 591-3, DOI:10.1111/j.1365-2133.2005.06460.x, PMID 15787848.
S. Aksoylar, Y. Aydinok; E. Serdaroğlu; M. Coker; F. Ozdemir; F. Ozkinay, HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome presenting with hypocalcemia-induced generalized psoriasis., in J Pediatr Endocrinol Metab, vol. 17, n. 7, luglio 2004, pp. 1031-4, PMID 15301053.
T. Maeda, H. Hasegawa; A. Matsuda; M. Kinoshita; O. Matsumura; T. Mitarai, [Severe hypocalcemia compatible with idiopathic hypoparathyroidism associated with psoriasis vulgaris]., in Nihon Naika Gakkai Zasshi, vol. 92, n. 12, dicembre 2003, pp. 2412-4, PMID 14743761.
Diani M, Altomare G, Reali E, T cell responses in psoriasis and psoriatic arthritis, in Autoimmun Rev, vol. 14, n. 4, 2015, pp. 286-92, DOI:10.1016/j.autrev.2014.11.012, PMID 25445403.
DC. ABELE, RL. DOBSON; JB. GRAHAM, HEREDITY AND PSORIASIS. STUDY OF A LARGE FAMILY., in Arch Dermatol, vol. 88, luglio 1963, pp. 38-47, PMID 14042660.
W. Watson, HM. Cann; EM. Farber; ML. Nall, The genetics of psoriasis., in Arch Dermatol, vol. 105, n. 2, febbraio 1972, pp. 197-207, PMID 5060862.
V. Chandran, CT. Schentag; JE. Brockbank; FJ. Pellett; S. Shanmugarajah; SM. Toloza; P. Rahman; DD. Gladman, Familial aggregation of psoriatic arthritis., in Ann Rheum Dis, vol. 68, n. 5, maggio 2009, pp. 664-7, DOI:10.1136/ard.2008.089367, PMID 18524791.
FO. Nestle, DH. Kaplan; J. Barker, Psoriasis., in N Engl J Med, vol. 361, n. 5, luglio 2009, pp. 496-509, DOI:10.1056/NEJMra0804595, PMID 19641206.
AM. Bowcock, JN. Barker, Genetics of psoriasis: the potential impact on new therapies., in J Am Acad Dermatol, vol. 49, 2 Suppl, agosto 2003, pp. S51-6, PMID 12894126.
A. Pasić, J. Lipozencić; R. Ceović; K. Kostović, The genetics of psoriasis--selected novelties in 2008., in Acta Dermatovenerol Croat, vol. 17, n. 3, 2009, pp. 176-81, PMID 19818216.
LD. Sun, W. Li; S. Yang; X. Fan; KL. Yan; YH. Liang; M. Gao; Y. Cui; FL. Xiao; WH. Du; KY. Zhang, Evidence for a novel psoriasis susceptibility locus at 9q33-9q34 in Chinese Hans., in J Invest Dermatol, vol. 127, n. 5, maggio 2007, pp. 1140-4, DOI:10.1038/sj.jid.5700671, PMID 17205061.
Gudjónsson JE, Kárason A, Antonsdóttir AA, Rúnarsdóttir EH, Gulcher JR, Stefánsson K, Valdimarsson H, HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features, in J. Invest. Dermatol., vol. 118, n. 2, 2002, pp. 362-5, DOI:10.1046/j.0022-202x.2001.01656.x, PMID 11841557.
RO. Leder, JN. Mansbridge; J. Hallmayer; SE. Hodge, Familial psoriasis and HLA-B: unambiguous support for linkage in 97 published families., in Hum Hered, vol. 48, n. 4, pp. 198-211, PMID 9694251.
Yim SH, Jung SH, Chung B, Chung YJ, Clinical implications of copy number variations in autoimmune disorders, in Korean J. Intern. Med., vol. 30, n. 3, 2015, pp. 294-304, DOI:10.3904/kjim.2015.30.3.294, PMC 4438283, PMID 25995659.
M. Cargill, SJ. Schrodi; M. Chang; VE. Garcia; R. Brandon; KP. Callis; N. Matsunami; KG. Ardlie; D. Civello; JJ. Catanese; DU. Leong, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes., in Am J Hum Genet, vol. 80, n. 2, febbraio 2007, pp. 273-90, DOI:10.1086/511051, PMID 17236132.
RP. Nair, A. Ruether; PE. Stuart; S. Jenisch; T. Tejasvi; R. Hiremagalore; S. Schreiber; D. Kabelitz; HW. Lim; JJ. Voorhees; E. Christophers, Polymorphisms of the IL12B and IL23R genes are associated with psoriasis., in J Invest Dermatol, vol. 128, n. 7, luglio 2008, pp. 1653-61, DOI:10.1038/sj.jid.5701255, PMID 18219280.
JE. Gudjonsson, Genetic variation and psoriasis., in G Ital Dermatol Venereol, vol. 143, n. 5, ottobre 2008, pp. 299-305, PMID 18833071.
CT. Jordan, L. Cao; ED. Roberson; S. Duan; CA. Helms; RP. Nair; KC. Duffin; PE. Stuart; D. Goldgar; G. Hayashi; EH. Olfson, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 796-808, DOI:10.1016/j.ajhg.2012.03.013, PMID 22521419.
CT. Jordan, L. Cao; ED. Roberson; KC. Pierson; CF. Yang; CE. Joyce; C. Ryan; S. Duan; CA. Helms; Y. Liu; Y. Chen, PSORS2 is due to mutations in CARD14., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 784-95, DOI:10.1016/j.ajhg.2012.03.012, PMID 22521418.
BJ. Nickoloff, The immunologic and genetic basis of psoriasis., in Arch Dermatol, vol. 135, n. 9, settembre 1999, pp. 1104-10, PMID 10490116.
DY. Leung, JB. Travers; R. Giorno; DA. Norris; R. Skinner; J. Aelion; LV. Kazemi; MH. Kim; AE. Trumble; M. Kotb, Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis., in J Clin Invest, vol. 96, n. 5, novembre 1995, pp. 2106-12, DOI:10.1172/JCI118263, PMID 7593594.
JE. Rasmussen, The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis., in Pediatr Infect Dis J, vol. 19, n. 2, febbraio 2000, pp. 153-4, PMID 10694004.
Boehncke WH, Schön MP, Psoriasis, in Lancet, 2015, DOI:10.1016/S0140-6736(14)61909-7, PMID 26025581.
Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C, Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety, in J Psychosom Res, 2015, DOI:10.1016/j.jpsychores.2015.04.008, PMID 25935351.
Trifunović J, Miller L, Debeljak Ž, Horvat V, Pathologic patterns of interleukin 10 expression--a review, in Biochem Med (Zagreb), vol. 25, n. 1, 2015, pp. 36-48, DOI:10.11613/BM.2015.004, PMC 4401305, PMID 25672465.
RJ. Chalmers, B. Kirby, Gluten and psoriasis., in Br J Dermatol, vol. 142, n. 1, gennaio 2000, pp. 5-7, PMID 10651687.
G. Michaëlsson, B. Gerdén; E. Hagforsen; B. Nilsson; I. Pihl-Lundin; W. Kraaz; G. Hjelmquist; L. Lööf, Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet., in Br J Dermatol, vol. 142, n. 1, gennaio 2000, pp. 44-51, PMID 10651693.
G. Michaëlsson, S. Ahs; I. Hammarström; IP. Lundin; E. Hagforsen, Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis., in Acta Derm Venereol, vol. 83, n. 6, 2003, pp. 425-9, DOI:10.1080/00015550310015022, PMID 14690336.
G. Addolorato, A. Parente; G. de Lorenzi; ME. D'angelo Di Paola; L. Abenavoli; L. Leggio; E. Capristo; C. De Simone; M. Rotoli; GL. Rapaccini; G. Gasbarrini, Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature., in Digestion, vol. 68, n. 1, 2003, pp. 9-12, PMID 12949434.
A. Civatte, Psoriasis and Seborrhœic Eczema: Pathological Anatomy and Diagnostic Histology of the Two Dermatoses., in Proc R Soc Med, vol. 18, Dermatol Sect, 1925, pp. 1-11, PMID 20908652.
HW. Barber, Pustular Psoriasis of the Extremities., in Proc R Soc Med, vol. 26, n. 4, febbraio 1933, pp. 329-33, PMID 19989109.
TJ. Jaime, BA. Rodrigues; TJ. Jaime; ML. Barbo; DR. Simis, [Psoriasis of von Zumbusch., in An Bras Dermatol, vol. 84, n. 3, luglio 2009, pp. 299-301, PMID 19668933.
F. Sampogna, MM. Chren; CF. Melchi; P. Pasquini; S. Tabolli; D. Abeni, Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis., in Br J Dermatol, vol. 154, n. 2, febbraio 2006, pp. 325-31, DOI:10.1111/j.1365-2133.2005.06909.x, PMID 16433804.
L. Dubertret, U. Mrowietz; A. Ranki; PC. van de Kerkhof; S. Chimenti; T. Lotti; G. Schäfer, European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey., in Br J Dermatol, vol. 155, n. 4, ottobre 2006, pp. 729-36, DOI:10.1111/j.1365-2133.2006.07405.x, PMID 16965422.
MJ. Bhosle, A. Kulkarni; SR. Feldman; R. Balkrishnan, Quality of life in patients with psoriasis., in Health Qual Life Outcomes, vol. 4, 2006, p. 35, DOI:10.1186/1477-7525-4-35, PMID 16756666.
D. Globe, MS. Bayliss; DJ. Harrison, The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups., in Health Qual Life Outcomes, vol. 7, 2009, p. 62, DOI:10.1186/1477-7525-7-62, PMID 19580674.
A. Gottlieb, J. Feng; DJ. Harrison; D. Globe, Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis., in J Am Acad Dermatol, vol. 63, n. 4, ottobre 2010, pp. 580-6, DOI:10.1016/j.jaad.2009.09.049, PMID 20599294.
T. Fredriksson, U. Pettersson, Severe psoriasis--oral therapy with a new retinoid., in Dermatologica, vol. 157, n. 4, 1978, pp. 238-44, PMID 357213.
BA. Louden, DJ. Pearce; W. Lang; SR. Feldman, A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients., in Dermatol Online J, vol. 10, n. 2, 2004, p. 7, PMID 15530297.
SR. Feldman, AB. Fleischer; DM. Reboussin; SR. Rapp; ML. Exum; AR. Clark; L. Nurre, The self-administered psoriasis area and severity index is valid and reliable., in J Invest Dermatol, vol. 106, n. 1, gennaio 1996, pp. 183-6, PMID 8592072.
K. Holubar, H. Auspitz, The man behind the eponym. Remembering Heinrich Auspitz., in Am J Dermatopathol, vol. 8, n. 1, febbraio 1986, pp. 83-5, PMID 3518525.
JD. Bernhard, Auspitz sign is not sensitive or specific for psoriasis., in J Am Acad Dermatol, vol. 22, 6 Pt 1, giugno 1990, pp. 1079-81, PMID 2370333.
MT. Rahman, NS. Monami; S. Ferdousi; T. Tahmin, Skin biopsy and psoriasis., in Mymensingh Med J, vol. 19, n. 3, luglio 2010, pp. 353-9, PMID 20639826.
K. Nayek, MK. Dasgupta, Infantile pustular psoriasis--may mimic seborrhic dermatitis., in Indian Pediatr, vol. 38, n. 9, settembre 2001, p. 1059, PMID 11568388.
A. Krol, B. Krafchik, The differential diagnosis of atopic dermatitis in childhood., in Dermatol Ther, vol. 19, n. 2, Ago 2009, pp. 73-82, DOI:10.1111/j.1529-8019.2006.00058.x, PMID 16669989.
GD. Eslick, Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis., in Int J Dermatol, vol. 41, n. 11, novembre 2002, pp. 788-91, PMID 12453007.
N. Balato, L. Di Costanzo; A. Balato, Differential diagnosis of psoriasis., in J Rheumatol Suppl, vol. 83, agosto 2009, pp. 24-5, DOI:10.3899/jrheum.090216, PMID 19661533.
A. Menter, CE. Griffiths, Current and future management of psoriasis., in Lancet, vol. 370, n. 9583, luglio 2007, pp. 272-84, DOI:10.1016/S0140-6736(07)61129-5, PMID 17658398.
A. Krebs, H. Schaltegger, [Investigations on the mechanism of action of chrysarobin and dithranol (=Cignolin) in psoriasis. Indications for a cytostatic action of these drugs]., in Experientia, vol. 21, n. 3, marzo 1965, pp. 128-9, PMID 5890422.
AC. Miller, Anthralin cream as short contact therapy for psoriasis., in Cutis, vol. 35, n. 6, giugno 1985, pp. 578-82, PMID 4017653.
N. Haas, A. Wulff-Woesten; W. Sterry; H. Meffert, [Dithranol in the treatment of scalp psoriasis]., in J Dtsch Dermatol Ges, vol. 1, n. 9, settembre 2003, pp. 688-93, PMID 16285275.
J. Fuchs, G. Zimmer; RH. Wölbling; R. Milbradt, On the interaction between anthralin and mitochondria: a revision., in Arch Dermatol Res, vol. 279, n. 1, 1986, pp. 59-65, PMID 2880567.
JC. Beani, M. Jeanmougin, [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]., in Ann Dermatol Venereol, vol. 137, n. 1, gennaio 2010, pp. 21-31, DOI:10.1016/j.annder.2009.12.004, PMID 20110064.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 11-21, DOI:10.1111/j.1468-3083.2012.04519.x, PMID 22512676.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 22-31, DOI:10.1111/j.1468-3083.2012.04520.x, PMID 22512677.
RV. Patel, LN. Clark; M. Lebwohl; JM. Weinberg, Treatments for psoriasis and the risk of malignancy., in J Am Acad Dermatol, vol. 60, n. 6, giugno 2009, pp. 1001-17, DOI:10.1016/j.jaad.2008.12.031, PMID 19344980.
RK. Landow, New drugs for dermatologic diseases., in Dermatol Clin, vol. 6, n. 4, ottobre 1988, pp. 575-84, PMID 3067917.
A. Kuhn, V. Ruland; N. Patsinakidis; TA. Luger, Use of methotrexate in patients with psoriasis., in Clin Exp Rheumatol, vol. 28, 5 Suppl 61, set-ott 2010, pp. S138-44, PMID 21044448.
PS. Yamauchi, D. Rizk; NJ. Lowe, Retinoid therapy for psoriasis., in Dermatol Clin, vol. 22, n. 4, ottobre 2004, pp. 467-76, x, DOI:10.1016/S0733-8635(03)00126-8, PMID 15450342.
P. Berbis, [Acitretine]., in Ann Dermatol Venereol, vol. 128, n. 6-7, Giu-Lug 2001, pp. 737-45, PMID 11460037.
Lernia V, Tasin L, Pellicano R, Zumiani G, Albertini G, Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis ^{[collegamento interrotto]}, in J Dermatolog Treat, vol. 23, n. 6, 2012, pp. 404-9, DOI:10.3109/09546634.2011.593489, PMID 21781016.
Benson JM, Peritt D, Scallon BJ, et al., Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders, in MAbs, vol. 3, n. 6, 2011, pp. 535-45, DOI:10.4161/mabs.3.6.17815, PMID 22123062.
Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH, Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses, in Br J Dermatol, vol. 168, n. 5, 2013, pp. 954-67, DOI:10.1111/bjd.12276/full, PMID 23413913.
Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F., Genetics of Psoriasis and Pharmacogenetics of Biological Drugs, in Autoimmune Dis., vol. 2013, n. 613086, agosto 2013, p. 613086, DOI:10.1155/2013/613086, PMC 3771250, PMID 24069534.
Parrish L., Psoriasis: symptoms, treatments and its impact on quality of life, in Br J Community Nurs, vol. 17, n. 11, 2012, pp. 524, 526, 528, DOI:10.12968/bjcn.2012.17.11.524, PMID 23124421.
Dessinioti C, Katsambas A, Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies, in Clin Dermatol, vol. 31, n. 4, 2013, pp. 343-51, DOI:10.1016/j.clindermatol.2013.01.001, PMID 23806151.
Menter, A.,Gottlieb, A., Feldman, S.R., Van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., Lebwohl, M., Koo, JY., Elmets, C.A., Korman, N.J., Beutner, K.R., Bhushan, R., Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics, in J Am Acad Dermatol, vol. 58, n. 5, maggio 2008, pp. 826-50, DOI:10.1016/j.jaad.2008.02.039, PMID 18423260.
Gelmetti C, Therapeutic moisturizers as adjuvant therapy for psoriasis patients, in Am J Clin Dermatol, vol. 10, Suppl 1, gennaio 2009, pp. 7-12, DOI:10.2165/0128071-200910001-00002, PMID 19209948.
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R, Quality of life in patients with psoriasis, in Health Qual Life Outcomes, vol. 4, 2006, p. 35, DOI:10.1186/1477-7525-4-35, PMC 1501000, PMID 16756666.
P Magin, Appearance-related bullying and skin disorders., in Clinics in dermatology, vol. 31, n. 1, Jan–Feb 2013, pp. 66-71, DOI:10.1016/j.clindermatol.2011.11.009, PMID 23245976.
Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Kimball AB, Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-related Comorbidities, in Am J Med, vol. 127, n. 12, dicembre 2014, pp. 1148-53, DOI:10.1016/j.amjmed.2014.08.008, PMID 25149424.
Armstrong AW, Harskamp CT, Armstrong EJ, Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis, in JAMA Dermatol, vol. 149, n. 1, gennaio 2013, pp. 84-91, DOI:10.1001/2013.jamadermatol.406, PMID 23407990.
Richard MA, Barnetche T, Horreau C, Brenaut E, Pouplard C, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Ortonne JP, Paul C., Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion, in J Eur Acad Dermatol Venereol, vol. 27, Supplement 3, agosto 2013, pp. 2-11, DOI:10.1111/jdv.12162, PMID 23845148.
Armstrong AW, Harskamp CT, Armstrong EJ, The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies, in J Hypertens, vol. 31, n. 3, 2013, pp. 433-42, DOI:10.1097/HJH.0b013e32835bcce1, PMID 23249828.
Ghazizadeh R, Tosa M, Ghazizadeh M, Clinical Improvement in Psoriasis with Treatment of Associated Hyperlipidemia, in Am J Med Sci, vol. 341, n. 5, 2011, pp. 394-8, DOI:10.1097/MAJ.0b013e3181ff8eeb, PMID 21233693.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP, Diagnosis and classification of psoriasis, in Autoimmun Rev, S1568-9972, n. 14, gennaio 2014, pp. 00020-2, DOI:10.1016/j.autrev.2014.01.008, PMID 24434359.
Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR, Risk of cardiovascular disorders in psoriasis patients: current and future, in Am J Clin Dermatol, vol. 14, n. 1, febbraio 2013, pp. 1-7, DOI:10.1007/s40257-012-0005-5, PMID 23329076.

oadoi.org

WH. Boehncke, S. Boehncke, Research in practice: the systemic aspects of psoriasis., in J Dtsch Dermatol Ges, vol. 6, n. 8, agosto 2008, pp. 622-5, DOI:10.1111/j.1610-0387.2008.06785.x, PMID 18564207.
WH. Boehncke, S. Boehncke, Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives., in Curr Rheumatol Rep, vol. 14, n. 4, agosto 2012, pp. 343-8, DOI:10.1007/s11926-012-0260-8, PMID 22562431.
T. Xu, Y. Zhang, Association Of Psoriasis With Stroke And Myocardial Infarction: Meta Analysis Of Cohort Studies., in Br J Dermatol, agosto 2012, DOI:10.1111/bjd.12002, PMID 22897416.
C. Kahl, B. Hansen; K. Reich, [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy]., in Hautarzt, vol. 63, n. 3, marzo 2012, pp. 184-91, DOI:10.1007/s00105-011-2228-4, PMID 22382303.
MS. Day, D. Nam; S. Goodman; EP. Su; M. Figgie, Psoriatic arthritis., in J Am Acad Orthop Surg, vol. 20, n. 1, gennaio 2012, pp. 28-37, DOI:10.5435/JAAOS-20-01-028, PMID 22207516.
H. Takahashi, K. Nakamura; F. Kaneko; H. Nakagawa; H. Iizuka, Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008., in J Dermatol, vol. 38, n. 12, dicembre 2011, pp. 1125-9, DOI:10.1111/j.1346-8138.2010.01145.x, PMID 21951304.
MA. de Rie, AY. Goedkoop; JD. Bos, Overview of psoriasis., in Dermatol Ther, vol. 17, n. 5, 2004, pp. 341-9, DOI:10.1111/j.1396-0296.2004.04037.x, PMID 15379769.
JM. Gelfand, R. Weinstein; SB. Porter; AL. Neimann; JA. Berlin; DJ. Margolis, Prevalence and treatment of psoriasis in the United Kingdom: a population-based study., in Arch Dermatol, vol. 141, n. 12, dicembre 2005, pp. 1537-41, DOI:10.1001/archderm.141.12.1537, PMID 16365254.
L. Naldi, P. Colombo; EB. Placchesi; R. Piccitto; L. Chatenoud; C. La Vecchia, Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population., in Dermatology, vol. 208, n. 1, 2004, pp. 38-42, DOI:10.1159/000075044, PMID 14730235.
R. Parisi, DP. Symmons; CE. Griffiths; DM. Ashcroft, Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence., in J Invest Dermatol, settembre 2012, DOI:10.1038/jid.2012.339, PMID 23014338.
V. Chandran, SP. Raychaudhuri, Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis., in J Autoimmun, vol. 34, n. 3, maggio 2010, pp. J314-21, DOI:10.1016/j.jaut.2009.12.001, PMID 20034760.
R. Zenz, R. Eferl; L. Kenner; L. Florin; L. Hummerich; D. Mehic; H. Scheuch; P. Angel; E. Tschachler; EF. Wagner, Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins., in Nature, vol. 437, n. 7057, settembre 2005, pp. 369-75, DOI:10.1038/nature03963, PMID 16163348.
R. de Cid, E. Riveira-Munoz; PL. Zeeuwen; J. Robarge; W. Liao; EN. Dannhauser; E. Giardina; PE. Stuart; R. Nair; C. Helms; G. Escaramís, Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis., in Nat Genet, vol. 41, n. 2, febbraio 2009, pp. 211-5, DOI:10.1038/ng.313, PMID 19169253.
L. Naldi, L. Peli; F. Parazzini; CF. Carrel, Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study., in J Am Acad Dermatol, vol. 44, n. 3, marzo 2001, pp. 433-8, DOI:10.1067/mjd.2001.110876, PMID 11209111.
CM. Owen, RJ. Chalmers; T. O'Sullivan; CE. Griffiths, Antistreptococcal interventions for guttate and chronic plaque psoriasis., in Cochrane Database Syst Rev, n. 2, 2000, pp. CD001976, DOI:10.1002/14651858.CD001976, PMID 10796842.
J. Badger, TG. Berger; C. Gambla; JY. Koo, HIV and psoriasis., in Clin Rev Allergy Immunol, vol. 14, n. 4, pp. 417-31, DOI:10.1007/BF02771755, PMID 9040969.
E. Mallon, CB. Bunker, HIV-associated psoriasis., in AIDS Patient Care STDS, vol. 14, n. 5, maggio 2000, pp. 239-46, DOI:10.1089/108729100317696, PMID 10833810.
E. Dika, F. Bardazzi; R. Balestri; HI. Maibach, Environmental factors and psoriasis., in Curr Probl Dermatol, vol. 35, 2007, pp. 118-35, DOI:10.1159/0000106419, PMID 17641494.
M. Afshar, AD. Martinez; RL. Gallo; TR. Hata, Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases., in J Eur Acad Dermatol Venereol, giugno 2012, DOI:10.1111/j.1468-3083.2012.04582.x, PMID 22671985.
L. Fry, BS. Baker, Triggering psoriasis: the role of infections and medications., in Clin Dermatol, vol. 25, n. 6, pp. 606-15, DOI:10.1016/j.clindermatol.2007.08.015, PMID 18021899.
S. Jankovic, M. Raznatovic; J. Marinkovic; J. Jankovic; N. Maksimovic, Risk factors for psoriasis: A case-control study., in J Dermatol, vol. 36, n. 6, giugno 2009, pp. 328-34, DOI:10.1111/j.1346-8138.2009.00648.x, PMID 19500181.
RP. Dellavalle, KR. Johnson, Do smoking, obesity, and stress cause psoriasis?, in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. vi-vii, DOI:10.1111/j.0022-202X.2005.23792.x, PMID 15982291.
L. Naldi, L. Chatenoud; D. Linder; A. Belloni Fortina; A. Peserico; AR. Virgili; PL. Bruni; V. Ingordo; G. Lo Scocco; C. Solaroli; D. Schena, Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study., in J Invest Dermatol, vol. 125, n. 1, luglio 2005, pp. 61-7, DOI:10.1111/j.0022-202X.2005.23681.x, PMID 15982303.
Diani M, Altomare G, Reali E, T cell responses in psoriasis and psoriatic arthritis, in Autoimmun Rev, vol. 14, n. 4, 2015, pp. 286-92, DOI:10.1016/j.autrev.2014.11.012, PMID 25445403.
V. Chandran, CT. Schentag; JE. Brockbank; FJ. Pellett; S. Shanmugarajah; SM. Toloza; P. Rahman; DD. Gladman, Familial aggregation of psoriatic arthritis., in Ann Rheum Dis, vol. 68, n. 5, maggio 2009, pp. 664-7, DOI:10.1136/ard.2008.089367, PMID 18524791.
FO. Nestle, DH. Kaplan; J. Barker, Psoriasis., in N Engl J Med, vol. 361, n. 5, luglio 2009, pp. 496-509, DOI:10.1056/NEJMra0804595, PMID 19641206.
LD. Sun, W. Li; S. Yang; X. Fan; KL. Yan; YH. Liang; M. Gao; Y. Cui; FL. Xiao; WH. Du; KY. Zhang, Evidence for a novel psoriasis susceptibility locus at 9q33-9q34 in Chinese Hans., in J Invest Dermatol, vol. 127, n. 5, maggio 2007, pp. 1140-4, DOI:10.1038/sj.jid.5700671, PMID 17205061.
RP. Nair, A. Ruether; PE. Stuart; S. Jenisch; T. Tejasvi; R. Hiremagalore; S. Schreiber; D. Kabelitz; HW. Lim; JJ. Voorhees; E. Christophers, Polymorphisms of the IL12B and IL23R genes are associated with psoriasis., in J Invest Dermatol, vol. 128, n. 7, luglio 2008, pp. 1653-61, DOI:10.1038/sj.jid.5701255, PMID 18219280.
CT. Jordan, L. Cao; ED. Roberson; S. Duan; CA. Helms; RP. Nair; KC. Duffin; PE. Stuart; D. Goldgar; G. Hayashi; EH. Olfson, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 796-808, DOI:10.1016/j.ajhg.2012.03.013, PMID 22521419.
CT. Jordan, L. Cao; ED. Roberson; KC. Pierson; CF. Yang; CE. Joyce; C. Ryan; S. Duan; CA. Helms; Y. Liu; Y. Chen, PSORS2 is due to mutations in CARD14., in Am J Hum Genet, vol. 90, n. 5, maggio 2012, pp. 784-95, DOI:10.1016/j.ajhg.2012.03.012, PMID 22521418.
Boehncke WH, Schön MP, Psoriasis, in Lancet, 2015, DOI:10.1016/S0140-6736(14)61909-7, PMID 26025581.
Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C, Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety, in J Psychosom Res, 2015, DOI:10.1016/j.jpsychores.2015.04.008, PMID 25935351.
G. Michaëlsson, S. Ahs; I. Hammarström; IP. Lundin; E. Hagforsen, Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis., in Acta Derm Venereol, vol. 83, n. 6, 2003, pp. 425-9, DOI:10.1080/00015550310015022, PMID 14690336.
MJ. Bhosle, A. Kulkarni; SR. Feldman; R. Balkrishnan, Quality of life in patients with psoriasis., in Health Qual Life Outcomes, vol. 4, 2006, p. 35, DOI:10.1186/1477-7525-4-35, PMID 16756666.
D. Globe, MS. Bayliss; DJ. Harrison, The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups., in Health Qual Life Outcomes, vol. 7, 2009, p. 62, DOI:10.1186/1477-7525-7-62, PMID 19580674.
A. Gottlieb, J. Feng; DJ. Harrison; D. Globe, Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis., in J Am Acad Dermatol, vol. 63, n. 4, ottobre 2010, pp. 580-6, DOI:10.1016/j.jaad.2009.09.049, PMID 20599294.
A. Krol, B. Krafchik, The differential diagnosis of atopic dermatitis in childhood., in Dermatol Ther, vol. 19, n. 2, Ago 2009, pp. 73-82, DOI:10.1111/j.1529-8019.2006.00058.x, PMID 16669989.
N. Balato, L. Di Costanzo; A. Balato, Differential diagnosis of psoriasis., in J Rheumatol Suppl, vol. 83, agosto 2009, pp. 24-5, DOI:10.3899/jrheum.090216, PMID 19661533.
A. Menter, CE. Griffiths, Current and future management of psoriasis., in Lancet, vol. 370, n. 9583, luglio 2007, pp. 272-84, DOI:10.1016/S0140-6736(07)61129-5, PMID 17658398.
JC. Beani, M. Jeanmougin, [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]., in Ann Dermatol Venereol, vol. 137, n. 1, gennaio 2010, pp. 21-31, DOI:10.1016/j.annder.2009.12.004, PMID 20110064.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 11-21, DOI:10.1111/j.1468-3083.2012.04519.x, PMID 22512676.
E. Archier, S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; P. Joly; D. Jullien, Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review., in J Eur Acad Dermatol Venereol, 26 Suppl 3, maggio 2012, pp. 22-31, DOI:10.1111/j.1468-3083.2012.04520.x, PMID 22512677.
RV. Patel, LN. Clark; M. Lebwohl; JM. Weinberg, Treatments for psoriasis and the risk of malignancy., in J Am Acad Dermatol, vol. 60, n. 6, giugno 2009, pp. 1001-17, DOI:10.1016/j.jaad.2008.12.031, PMID 19344980.
Benson JM, Peritt D, Scallon BJ, et al., Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders, in MAbs, vol. 3, n. 6, 2011, pp. 535-45, DOI:10.4161/mabs.3.6.17815, PMID 22123062.
Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH, Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses, in Br J Dermatol, vol. 168, n. 5, 2013, pp. 954-67, DOI:10.1111/bjd.12276/full, PMID 23413913.
Parrish L., Psoriasis: symptoms, treatments and its impact on quality of life, in Br J Community Nurs, vol. 17, n. 11, 2012, pp. 524, 526, 528, DOI:10.12968/bjcn.2012.17.11.524, PMID 23124421.
Dessinioti C, Katsambas A, Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies, in Clin Dermatol, vol. 31, n. 4, 2013, pp. 343-51, DOI:10.1016/j.clindermatol.2013.01.001, PMID 23806151.
Menter, A.,Gottlieb, A., Feldman, S.R., Van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., Lebwohl, M., Koo, JY., Elmets, C.A., Korman, N.J., Beutner, K.R., Bhushan, R., Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics, in J Am Acad Dermatol, vol. 58, n. 5, maggio 2008, pp. 826-50, DOI:10.1016/j.jaad.2008.02.039, PMID 18423260.
Gelmetti C, Therapeutic moisturizers as adjuvant therapy for psoriasis patients, in Am J Clin Dermatol, vol. 10, Suppl 1, gennaio 2009, pp. 7-12, DOI:10.2165/0128071-200910001-00002, PMID 19209948.
P Magin, Appearance-related bullying and skin disorders., in Clinics in dermatology, vol. 31, n. 1, Jan–Feb 2013, pp. 66-71, DOI:10.1016/j.clindermatol.2011.11.009, PMID 23245976.
Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Kimball AB, Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-related Comorbidities, in Am J Med, vol. 127, n. 12, dicembre 2014, pp. 1148-53, DOI:10.1016/j.amjmed.2014.08.008, PMID 25149424.
Armstrong AW, Harskamp CT, Armstrong EJ, Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis, in JAMA Dermatol, vol. 149, n. 1, gennaio 2013, pp. 84-91, DOI:10.1001/2013.jamadermatol.406, PMID 23407990.
Richard MA, Barnetche T, Horreau C, Brenaut E, Pouplard C, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Ortonne JP, Paul C., Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion, in J Eur Acad Dermatol Venereol, vol. 27, Supplement 3, agosto 2013, pp. 2-11, DOI:10.1111/jdv.12162, PMID 23845148.
Armstrong AW, Harskamp CT, Armstrong EJ, The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies, in J Hypertens, vol. 31, n. 3, 2013, pp. 433-42, DOI:10.1097/HJH.0b013e32835bcce1, PMID 23249828.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP, Diagnosis and classification of psoriasis, in Autoimmun Rev, S1568-9972, n. 14, gennaio 2014, pp. 00020-2, DOI:10.1016/j.autrev.2014.01.008, PMID 24434359.
Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR, Risk of cardiovascular disorders in psoriasis patients: current and future, in Am J Clin Dermatol, vol. 14, n. 1, febbraio 2013, pp. 1-7, DOI:10.1007/s40257-012-0005-5, PMID 23329076.

pharmastar.it

PHARMASTAR - L'Emea raccomanda la sospensione dell'antipsoriasi Efalizumab

web.archive.org

Malattie a carattere desquamativo, su msd-italia.it. URL consultato il 22 novembre 2011 (archiviato dall'url originale il 29 gennaio 2013).
Raccomandazione EMEA su base della NOTA INFORMATIVA dell'AIFA (PDF), su agenziafarmaco.it. URL consultato il 7 luglio 2010 (archiviato dall'url originale il 28 novembre 2009).
Voluntary US Market Discontinuation of Amevive® (alefacept) (PDF), su amevive.com. URL consultato il 1º dicembre 2012 (archiviato dall'url originale il 17 agosto 2013).